Search company, investor...

Predict your next investment

Altitude Life Science Ventures company logo
Venture Capital
altitudelsv.com

Investments

55

Portfolio Exits

20

Funds

5

About Altitude Life Science Ventures

Altitude Life Science Ventures seeks opportunities to invest in early stage life science companies within markets with significant demand and growth potential, and then backs the highest-quality teams in those markets to build defensible, strong, and long-term businesses. At Altitude, our scope of investment opportunities extends beyond prescription drugs to any commercial application of proprietary technology that originates from a key advance in biology or chemistry.

Headquarters Location

1014 Market St., Suite 200

Kirkland, Washington, 98033,

United States

650-843-5000

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest Altitude Life Science Ventures News

Mozart Therapeutics lands $25M to develop therapies for autoimmune, inflammatory diseases

Jun 7, 2023

(Mozart Photo)New funding: Seattle biotech company Mozart Therapeutics announced $25 million in new funding Wednesday to further its development of therapies for celiac and other autoimmune conditions.The therapy: The fresh cash will be used to accelerate the development of MTX-101, Mozart’s leading drug candidate.Other competitors include GentiBio, which is building operations in Boston and Seattle, Egle Therapeutics, TRex Bio, and Avotres.The funding: The extended Series A round includes participation from Pfizer Ventures, AbbVie Ventures, Ono Venture Investment and UPMC Enterprises.Previous backers include Mozart investors ARCH Venture Partners, Sofinnova Partners, Eli Lilly & Company, MRL Ventures Fund, Leaps by Bayer, Altitude Life Science Ventures, and Alexandria Venture Investments. Disclaimer: This story is auto-aggregated & summarized by a computer program and has not been created by StartupAround.

Altitude Life Science Ventures Investments

55 Investments

Altitude Life Science Ventures has made 55 investments. Their latest investment was in Generate Biomedicines as part of their Series C on September 9, 2023.

CBI Logo

Altitude Life Science Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/14/2023

Series C

Generate Biomedicines

$273M

No

4

6/7/2023

Series A - II

Mozart Therapeutics

$25M

No

8

3/9/2023

Series C

Ring Therapeutics

$86.5M

No

2

11/28/2022

Series C

Subscribe to see more

$99M

Subscribe to see more

10

10/11/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/14/2023

6/7/2023

3/9/2023

11/28/2022

10/11/2022

Round

Series C

Series A - II

Series C

Series C

Series B

Company

Generate Biomedicines

Mozart Therapeutics

Ring Therapeutics

Subscribe to see more

Subscribe to see more

Amount

$273M

$25M

$86.5M

$99M

$99M

New?

No

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

4

8

2

10

10

Altitude Life Science Ventures Portfolio Exits

20 Portfolio Exits

Altitude Life Science Ventures has 20 portfolio exits. Their latest portfolio exit was Neumora on September 15, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/15/2023

IPO

$99M

Public

4

6/5/2023

Acq - Pending

$99M

2

9/15/2021

IPO

$99M

Public

3

8/5/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

7/20/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/15/2023

6/5/2023

9/15/2021

8/5/2021

7/20/2021

Exit

IPO

Acq - Pending

IPO

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Public

Subscribe to see more

Subscribe to see more

Sources

4

2

3

10

10

Altitude Life Science Ventures Fund History

5 Fund Histories

Altitude Life Science Ventures has 5 funds, including Altitude Life Science Ventures Side Fund III.

Closing Date

Fund

Fund Type

Status

Amount

Sources

1/22/2019

Altitude Life Science Ventures Side Fund III

$50M

1

3/19/2018

Altitude Life Science Ventures III

10

4/28/2015

Altitude Life Science Ventures II

$99M

10

4/27/2015

Altitude Life Science Ventures Fund II

10

Altitude Life Science Ventures Fund IV

10

Closing Date

1/22/2019

3/19/2018

4/28/2015

4/27/2015

Fund

Altitude Life Science Ventures Side Fund III

Altitude Life Science Ventures III

Altitude Life Science Ventures II

Altitude Life Science Ventures Fund II

Altitude Life Science Ventures Fund IV

Fund Type

Status

Amount

$50M

$99M

Sources

1

10

10

10

10

Altitude Life Science Ventures Team

1 Team Member

Altitude Life Science Ventures has 1 team member, including current Founder, David Maki.

Name

Work History

Title

Status

David Maki

Founder

Current

Name

David Maki

Work History

Title

Founder

Status

Current

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.